Indications
Treatment of bladder cancer in adults indicated for the treatment of adult indicated for treatement of bladder cancer.
Composition
- Active substance
- sasanlimab
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zumrad
- Active substance
- sasanlimab
- ATC code
- L01FF
- Therapeutic area
- Urinary Bladder Neoplasms
- Marketing authorisation holder
- Pfizer Europe MA EEIG
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/006641